Blood test shows promise in forecasting outcomes for germ cell tumors

Blood test shows promise in forecasting outcomes for germ cell tumors

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and Slovakia.

Blood test could help guide treatment decisions in germ cell tumors

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and Slovakia. They focused specifically on young adults with germ cell tumors for whom standard chemotherapy doesn't work well.

Liquid Biopsy May Refine High-Dose Chemotherapy Decisions in Relapsed Germ Cell Tumors

When standard chemotherapy fails in young men with germ cell tumors, options become limited and often grueling. High-dose chemotherapy can offer a second chance at durable remission, but for many, it comes at the cost of significant toxicity without long-term benefit. A new study published in the Journal of Clinical Oncology suggests that a simple blood test could help identify which patients are most likely to benefit from such intensive therap…